Bone mineral density and trabecular bone score in patients with 21-hydroxylase deficiency after glucocorticoid treatment.

Yinjie GaoOu WangWenmin GuanXueyan WuJiang-Feng MaoXi WangWei YuMin Nie

Published in: Clinical endocrinology (2021)

Approximately 24% of patients with 21-OHD had abnormal microarchitecture of their bone in our study, and TBS score was negatively correlated with daily glucocorticoid dosage in patients. TBS may be used alongside conventional BMD as a complementary marker for bone evaluation in 21-OHD patients.

Keyphrases

bone mineral density
postmenopausal women
end stage renal disease
newly diagnosed
body composition
ejection fraction
chronic kidney disease
peritoneal dialysis
patient reported outcomes
bone loss
soft tissue
patient reported